Lisinopril and Hydrochlorothiazide
- Product NDC
- 71335-2091
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide Tablets
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076230
- Marketing category
- ANDA
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 71335-2091-1 | 30 TABLET in 1 BOTTLE (71335-2091-1) | 2022-05-17 | | No | Historical |
| 71335-2091-2 | 60 TABLET in 1 BOTTLE (71335-2091-2) | 2022-05-17 | | No | Historical |
| 71335-2091-3 | 90 TABLET in 1 BOTTLE (71335-2091-3) | 2022-05-17 | | No | Historical |
| 71335-2091-4 | 120 TABLET in 1 BOTTLE (71335-2091-4) | 2022-05-17 | | No | Historical |
| 71335-2091-5 | 100 TABLET in 1 BOTTLE (71335-2091-5) | 2022-05-17 | | No | Historical |
| 71335-2091-6 | 180 TABLET in 1 BOTTLE (71335-2091-6) | 2022-05-17 | | No | Historical |